Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review
Primary central nervous system lymphoma (PCNSL) is a highly aggressive brain tumor with poor prognosis if no treatment. The activation of the NF-κB (nuclear factor kappa-B) is the oncogenic hallmark of PCNSL, and it was driven by B cell receptor (BCR) and Toll-like receptor (TLR) signaling pathways....
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2022-11-01
|
| Reeks: | Frontiers in Oncology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1034668/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|